Literature DB >> 1879935

Activation of bovine neutrophils by partially purified Pasteurella haemolytica leukotoxin.

C J Czuprynski1, E J Noel, O Ortiz-Carranza, S Srikumaran.   

Abstract

In this study we developed a new method for the partial purification of Pasteurella haemolytica leukotoxin by size-exclusion high-performance liquid chromatography. The partially purified leukotoxin had a molecular weight of 104,000, as estimated by using sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and reacted on an immunoblot with an antileukotoxin monoclonal antibody. As expected, high concentrations of the leukotoxin were inhibitory or lethal to bovine neutrophils. Incubation of bovine neutrophils with diluted leukotoxin, however, resulted in significant neutrophil activation that was comparable in magnitude to that obtained with standard activating agents such as opsonized zymosan or zymosan-activated serum. Dilute leukotoxin (1:128 to 1:8,192 dilutions) stimulated an oxidative burst (luminol-dependent chemiluminescence) by bovine neutrophils that was comparable in magnitude to that obtained with opsonized zymosan. Preincubation with leukotoxin did not significantly prime the neutrophils for an enhanced oxidative burst when they were then exposed to opsonized zymosan as a second stimulus. Dilute leukotoxin (1:100 to 1:1,000 dilutions) also stimulated cytoskeletal alterations in bovine neutrophils, as measured by a significant shape change response. Preferential release of secondary granule constituents (lactoferrin) occurred when neutrophils were incubated with 1:100 to 1:500 dilutions of leukotoxin. Significant release of primary granules, as measured by beta-glucosaminidase activity, was not observed except at low dilutions (1:20) of leukotoxin that resulted in significant release of cytosolic constituents (i.e., lactate dehydrogenase activity). The neutrophil-activating activity of the leukotoxin was heat labile, unaffected by polymyxin B, and abrogated by a leukotoxin-neutralizing monoclonal antibody. These data indicate that P. haemolytica leukotoxin, like the closely related Escherichia coli hemolysin, is a potent neutrophil-activating agent. Leukotoxin-stimulated release of neutrophil oxygen intermediates and granule constituents may contribute to the intense inflammation that characterizes bovine pulmonary pasteurellosis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1879935      PMCID: PMC258143          DOI: 10.1128/iai.59.9.3126-3133.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

Review 1.  Bovine pneumonic pasteurellosis: immunity to Pasteurella haemolytica.

Authors:  A W Confer; R J Panciera; D A Mosier
Journal:  J Am Vet Med Assoc       Date:  1988-11-15       Impact factor: 1.936

2.  Quantitative study of the binding and hemolytic efficiency of Escherichia coli hemolysin.

Authors:  B Eberspächer; F Hugo; S Bhakdi
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

3.  Transmembrane pore size and role of cell swelling in cytotoxicity caused by Pasteurella haemolytica leukotoxin.

Authors:  K D Clinkenbeard; D A Mosier; A W Confer
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

4.  Pore formation by the Escherichia coli hemolysin: evidence for an association-dissociation equilibrium of the pore-forming aggregates.

Authors:  R Benz; A Schmid; W Wagner; W Goebel
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

5.  Vaccination of calves with leukotoxic culture supernatant from Pasteurella haemolytica.

Authors:  P E Shewen; B N Wilkie
Journal:  Can J Vet Res       Date:  1988-01       Impact factor: 1.310

6.  Identification of a hemolysin from Actinobacillus pleuropneumoniae and characterization of its channel properties in planar phospholipid bilayers.

Authors:  G Lalonde; T V McDonald; P Gardner; P D O'Hanley
Journal:  J Biol Chem       Date:  1989-08-15       Impact factor: 5.157

7.  Regulation of expression of the Pasteurella haemolytica leukotoxin determinant.

Authors:  C A Strathdee; R Y Lo
Journal:  J Bacteriol       Date:  1989-11       Impact factor: 3.490

8.  Nucleotide sequence of the leukotoxin genes of Pasteurella haemolytica A1.

Authors:  R Y Lo; C A Strathdee; P E Shewen
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

9.  Priming and stimulation of bovine neutrophils by recombinant human interleukin-1 alpha and tumor necrosis factor alpha.

Authors:  A K Sample; C J Czuprynski
Journal:  J Leukoc Biol       Date:  1991-02       Impact factor: 4.962

10.  Role of Escherichia coli alpha-hemolysin and bacterial adherence in infection: requirement for release of inflammatory mediators from granulocytes and mast cells.

Authors:  B König; W König; J Scheffer; J Hacker; W Goebel
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

View more
  20 in total

1.  Inflammatory cytokines enhance the interaction of Mannheimia haemolytica leukotoxin with bovine peripheral blood neutrophils in vitro.

Authors:  F Leite; S O'Brien; M J Sylte; T Page; D Atapattu; C J Czuprynski
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

2.  Pasteurella haemolytica leukotoxin induces bovine leukocytes to undergo morphologic changes consistent with apoptosis in vitro.

Authors:  P K Stevens; C J Czuprynski
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  Recombinant bovine interleukin-1beta amplifies the effects of partially purified Pasteurella haemolytica leukotoxin on bovine neutrophils in a beta(2)-integrin-dependent manner.

Authors:  F Leite; J F Brown; M J Sylte; R E Briggs; C J Czuprynski
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

4.  Dissociation of cytolysis and monokine release by bovine mononuclear phagocytes incubated with Pasteurella haemolytica partially purified leukotoxin and lipopolysaccharide.

Authors:  P Stevens; C Czuprynski
Journal:  Can J Vet Res       Date:  1995-04       Impact factor: 1.310

5.  Inactivation of Pasteurella (Mannheimia) haemolytica leukotoxin causes partial attenuation of virulence in a calf challenge model.

Authors:  S K Highlander; N D Fedorova; D M Dusek; R Panciera; L E Alvarez; C Rinehart
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

6.  Pasteurella haemolytica leukotoxin-induced increase in phospholipase A2 activity in bovine neutrophils.

Authors:  Z Wang; C Clarke; K Clinkenbeard
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

7.  Mannheimia haemolytica leukotoxin activates a nonreceptor tyrosine kinase signaling cascade in bovine leukocytes, which induces biological effects.

Authors:  S Jeyaseelan; M S Kannan; R E Briggs; P Thumbikat; S K Maheswaran
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

8.  Use of operon fusions in Mannheimia haemolytica to identify environmental and cis-acting regulators of leukotoxin transcription.

Authors:  A M Marciel; S K Highlander
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

9.  The (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium) colorimetric assay for the quantitation of Actinobacillus pleuropneumoniae cytotoxin.

Authors:  W B Chung; L R Bäckström; J McDonald; M T Collins
Journal:  Can J Vet Res       Date:  1993-07       Impact factor: 1.310

10.  Possibility of separating toxins from bacteria associated with sudden infant death syndrome using anion exchange chromatography.

Authors:  D B Drucker; H A Aluyi; J A Morris; D R Telford; B A Oppenheim; B A Crawley
Journal:  J Clin Pathol       Date:  1992-09       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.